Add Popular Science (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results.

Lauren writes about healthcare AI data interoperability, the science behind public health recommendations, and pharmaceutical advances in the rare disease space. In a rare move, nonprofit organization ...

Data scarcity and class imbalance remain critical challenges in medical image analysis, particularly for brain tumor MRI segmentation, where subcomponents such as enhancing tumor, non-enhancing tumor, ...

A research team led by the University of Michigan College of Pharmacy and the University of Texas MD Anderson Cancer Center has developed a new type of nanoparticle therapy that could make cancer ...

A research team led by The Hong Kong University of Science and Technology (HKUST) has developed a pioneering artificial intelligence (AI) pathology analysis system that can accurately recognize ...

When Garry Buettner, PhD, who has been studying the chemistry and biochemistry of vitamin C for at least four decades, was diagnosed with myelodysplastic syndromes (MDS), he applied his research to ...

Multicentric Validation of a Complete Blood Count–Based Model for Breast Cancer Risk Stratification in Women Age 40-49 Years AI segmentation using Segment Anything Model 2 (SAM 2) was evaluated from ...

One common concern is whether these types of drinks cause cancer. Braden McFarland, Ph.D., associate professor in the University of Alabama at Birmingham Department of Cell, Developmental and ...

Talk about being a dedicated paw-rent. When his 8-year-old dog Rosie had mere months to live due to deadly mast cell cancerous tumors, Australian tech entrepreneur Paul Conyngham took matters into his ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Australian tech entrepreneur Paul Conyngham has used artificial ...

A redesigned cancer immunotherapy is showing striking early results after decades of disappointment with similar drugs. Researchers engineered a more powerful CD40 agonist antibody and changed how ...